Novo Nordisk A's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 18.31, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Novo Nordisk A in Mar 31 2026 quarter, has decreased to 20 days, compared to 43 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 277 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1991, from overall ranking in the fourth quarter 2025 at 1994.

What is Receivable Turnover Ratio?
What is Novo Nordisk A Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVO Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-	11.49 %	-	-	-
Y / Y Revenue Change	37.57 %	0.7 %	11.78 %	18.95 %	15.86 %
Receivable Turnover Ratio (TTM)	18.31	8.41	8.85	8.62	8.26
NVO's Total Ranking	# 1991	# 1994	#	#	#
Accounts Receivable average collection period days	20	43	41	42	44
Seq. Receivable Change	-	-	-	-	11.49 %
Seq. Revenue Change	22.55 %	5.42 %	0.48 %	5.98 %	-10.3 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 72
Healthcare Sector	# 278
Overall Market	# 1991

Receivable Turnover Ratio Statistics
High	Average	Low
1.04	0.78	0.57
(Dec 31 2018)		(Dec 31 2025)

NVO Company Profile • Back to NVO Efficiency Comparisons • Compare NVO Receivables Turnover Ratio to its Competitors

Financial Statements
Novo Nordisk A's Accounts Receivable	$ 0 Millions	Visit NVO's Balance sheet
Novo Nordisk A's Sales TTM	$ 50,962 Millions	Visit NVO's Income Statement
Sources of NVO's Revenues		Visit NVO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NVO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NVO's Growth Rates	NVO's Roa	NVO's Inventory Turnover Ratio	NVO's Dividend Comparisons
NVO's Profitability Ratios	NVO's Roi	NVO's Asset Turnover Ratio	NVO's Dividend Growth
NVO's Valuation Ratios	NVO's Roe	NVO's Financial Strength Ratios	NVO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2026

Receivable at quarter ending Mar 31 2026

Date modified: 2026-09-23T16:04:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.